Proteasome expression in the skeletal muscles of patients with muscular dystrophy

[1]  T. Kumamoto,et al.  Proteasomes in distal myopathy with rimmed vacuoles. , 1998, Internal medicine.

[2]  T. Murakami,et al.  Expression of three calpain isoform genes in human skeletal muscles , 1998, Journal of the Neurological Sciences.

[3]  A. Engel,et al.  Acute quadriplegic myopathy: Analysis of myosin isoforms and evidence for calpain‐mediated proteolysis , 1997, Muscle & nerve.

[4]  E. Kominami,et al.  Calpain and cathepsins in the skeletal muscle of inflammatory myopathies. , 1997, European neurology.

[5]  A. Goldberg,et al.  Mechanisms of muscle wasting. The role of the ubiquitin-proteasome pathway. , 1996, The New England journal of medicine.

[6]  S. E. Samuels,et al.  No alteration in gene expression of components of the ubiquitin proteasome proteolytic pathway in dystrophin‐deficient muscles , 1996, FEBS letters.

[7]  C. Guézennec,et al.  Coordinate activation of lysosomal, Ca 2+-activated and ATP-ubiquitin-dependent proteinases in the unweighted rat soleus muscle. , 1996, The Biochemical journal.

[8]  D. Breuillé,et al.  Muscle wasting in a rat model of long-lasting sepsis results from the activation of lysosomal, Ca2+ -activated, and ubiquitin-proteasome proteolytic pathways. , 1996, The Journal of clinical investigation.

[9]  A. Goldberg,et al.  Increase in ubiquitin-protein conjugates concomitant with the increase in proteolysis in rat skeletal muscle during starvation and atrophy denervation. , 1995, The Biochemical journal.

[10]  A. Goldberg,et al.  Increase in levels of polyubiquitin and proteasome mRNA in skeletal muscle during starvation and denervation atrophy. , 1995, The Biochemical journal.

[11]  G. Tiao,et al.  Sepsis stimulates nonlysosomal, energy-dependent proteolysis and increases ubiquitin mRNA levels in rat skeletal muscle. , 1994, The Journal of clinical investigation.

[12]  I. Nonaka,et al.  Immunohistochemical analysis of perforin and granzyme A in inflammatory myopathies , 1994, Neuromuscular Disorders.

[13]  D. E. Goll,et al.  Skeletal Muscle Proteases and Protein Turnover , 1989 .

[14]  Hideo Sugita,et al.  Immunostaining of skeletal and cardiac muscle surface membrane with antibody against Duchenne muscular dystrophy peptide , 1988, Nature.

[15]  Eric P. Hoffman,et al.  Dystrophin: The protein product of the duchenne muscular dystrophy locus , 1987, Cell.

[16]  P. A. Reddy,et al.  Calcium activated neutral proteases (milli- and micro-CANP) and endogenous CANP inhibitor of muscle in Duchenne muscular dystrophy (DMD). , 1986, Clinica chimica acta; international journal of clinical chemistry.

[17]  J. Bodensteiner,et al.  Intracellular calcium accumulation in Duchenne dystrophy and other myopathies , 1978, Neurology.

[18]  C. Pearson,et al.  A calcium-activated neutral protease in normal and dystrophic human muscle. , 1976, Clinica chimica acta; international journal of clinical chemistry.